Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Posted on by ScienceFather

Prof. Ammu Kutty Radhakrishnan | Cancer Immunology | Best Researcher Award

Prof. Ammu Kutty Radhakrishnan, Monash University Malaysia, Malaysia

 

Prof. Ammu Kutty Radhakrishnan is a distinguished immunologist with a PhD from the University of Cambridge (1994), an MSc in Biochemistry (1990), and a BSc (First Class Honours) from the University of Malaya (1987). Currently, a Professor of Immunology at Monash University Malaysia, she has over 25 years of academic leadership and research experience. Prof. Ammu specializes in immunotherapy and food as medicine research, serving as Head of this research strength. Her career spans significant roles at International Medical University and Oxford. She is a research consultant, active in COVID-19 vaccine efforts, and supervises PhD and MSc students. 🌿🧬📚

 

Publication Profile

Google Scholar

Academic Excellence

Prof. Ammu Kutty Radhakrishnan has an exceptional academic background, with a PhD in Immunology from the University of Cambridge (1994) and degrees in Biochemistry from the University of Malaya. Her education forms a solid foundation for her expertise in immunology and biomedical sciences, contributing to her distinguished career.

Professional Experience

Prof. Radhakrishnan has held key roles, such as Professor at Monash University Malaysia and the International Medical University (IMU). Her leadership in academic programs, such as head of the Food as Medicine Research Strength and chief examiner roles, showcases her commitment to advancing education and research.

Research Contributions

Prof. Radhakrishnan has supervised numerous PhD and Master’s students, guiding 39 doctoral and 20 master’s research projects to completion. Her extensive research supervision experience highlights her dedication to fostering scientific inquiry and innovation. Additionally, her collaborative efforts with industry partners demonstrate her ability to apply research to real-world problems.

Conclusion

Prof. Ammu Kutty Radhakrishnan’s outstanding academic credentials, extensive research supervision, leadership roles, and global health contributions, she is an ideal candidate for the Best Researcher Award. Her work in immunology, biomedicine, and collaboration with industry partners demonstrates her excellence in both academic and applied research, making her a worthy contender for this prestigious recognition.

 

Publication Top Notes  

  • Protective effect of aqueous extract from Spirulina platensis against cell death induced by free radicals (2010) – 292 citations 🧪
  • Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59 (1994) – 259 citations 🧬
  • Rind of the rambutan, Nephelium lappaceum, a potential source of natural antioxidants (2008) – 193 citations 🍇
  • Current concepts of neurodegenerative mechanisms in Alzheimer’s disease (2018) – 176 citations 🧠
  • Bioactive Compounds: Natural Defense Against Cancer? (2019) – 169 citations 🌿
  • Protective mechanisms of flavonoids in Parkinson’s disease (2015) – 162 citations 🧑‍⚕️
  • Tocotrienol research: past into present (2012) – 157 citations 🌰
  • Standardised Mangifera indica extract is an ideal antioxidant (2009) – 149 citations 🥭
  • Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson’s disease (2020) – 128 citations 🚀
  • Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice (2004) – 126 citations 🧫
  • Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity (2013) – 124 citations 🧪

 

Maryam Hosseini | Immunotherapy Award | Best Researcher Award

Posted on by ScienceFather

Dr. Maryam Hosseini | Immunotherapy Award | Best Researcher Award

Dr. Maryam Hosseini, Shiraz University of Medical Sciences, Iran

Dr. Maryam Hosseini is an Iranian immunologist specializing in immune-mediated diseases, cancer immunology, and therapy, based at the Trauma Research Center, Shiraz University of Medical Sciences. With a PhD in Immunology from Tarbiat Modares University, her research focuses on extracellular vesicles and non-coding RNAs in immune responses. She has published extensively and presented her work globally, including on colorectal cancer and COVID-19 immunology. Dr. Hosseini is skilled in a range of laboratory techniques and has contributed significantly to the field through her teaching and workshop participation. 🧬🔬

 

Publication profile

🔬 Education

Maryam’s research focuses on inflammation, cancer immunology, and immune therapy. Her doctoral thesis explored the role of exosome-enriched miRNA-34a from CT-26 cell lines in anti-tumor immune responses in colorectal cancer mouse models.

Awards

Maryam’s academic excellence is evident through numerous honors, including ranking first among MSc students and actively contributing to immunology committees in Iran.

🎓 Teaching

Maryam is also dedicated to education, having taught immunology courses at Azad University. Her commitment extends to organizing international congresses and workshops, enriching both scientific discourse and student learning.

Research Focus

Maryam Hosseini’s research focus spans across several critical areas in immunology and biotechnology 🧬. Her work prominently explores the use of nanoparticles in cancer immunotherapy, highlighting their potential as novel therapeutic agents. Additionally, she investigates CAR-modified T-cell therapies for cancer treatment, emphasizing advancements in personalized medicine. Amidst the COVID-19 pandemic, she contributed significantly to understanding immune responses and therapeutic challenges associated with the virus. Her studies also extend to the role of exosomes in tumor progression and immune modulation, showcasing her diverse contributions to both basic and applied immunological sciences. Maryam’s multidimensional approach underscores her commitment to advancing biomedical research with impactful implications.

 

Publication Top Notes